Jump to Header Jump to Main Content Jump to Footer

EchoTip AcuCore EUS Biopsy Needle Post-Market Study

Jason Samarasena


A Study On:

  • Cancer - Oncologic
  • Pancreatitis

Status:

  • Open

Eligibility

Adenocarcinoma
Neuroendocrine Tumors
Hepatocellular Carcinoma
Cholangiocarcinoma
Malignant Lymphoma
Metastasis
Chronic Pancreatitis
Autoimmune Pancreatitis
18 Years and older (Adult, Older Adult)

Official Title

EchoTip AcuCore EUS Biopsy Needle Post-Market Study


Eligibility

You can join if...

Inclusion Criteria:

  1. Patient has been referred for an endoscopic ultrasound (EUS) fine needle biopsy procedure
  2. The EchoTip AcuCore device is the first EUS biopsy needle used in the procedure.

Exclusion Criteria:

  1. Patient's age is less than 18 years
  2. Patient is unable or unwilling to sign and date the informed consent. If IRB approves a waiver of consent, this exclusion criterion is not applicable.
  3. Patient is simultaneously participating in another pre-market investigational drug or pre-market investigational device study involving an EUS fine needle biopsy procedure and for which the patient has not completed the follow-up phase for the primary endpoint at least 30 days prior to enrollment in this study.
  4. Inaccessible or unsuitable lesion (lesion not visualized or a large vessel, duct or primary mass interposition)

Get in touch with our study team